Author
Listed:
- Atsuo Kanno
(The Institute of Medical Science, The University of Tokyo
Laboratory of Innate Immunity, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo)
- Natsuko Tanimura
(The Institute of Medical Science, The University of Tokyo
Japan Society for the Promotion of Science)
- Masayuki Ishizaki
(Daiichi Sankyo Shinagawa R&D center, Daiichi Sankyo Co. Ltd.)
- Kentaro Ohko
(Kochi Medical School, Kochi University, Kohasu)
- Yuji Motoi
(The Institute of Medical Science, The University of Tokyo)
- Masahiro Onji
(Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences)
- Ryutaro Fukui
(The Institute of Medical Science, The University of Tokyo)
- Takaichi Shimozato
(Daiichi Sankyo Shinagawa R&D center, Daiichi Sankyo Co. Ltd.)
- Kazuhide Yamamoto
(Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences)
- Takuma Shibata
(The Institute of Medical Science, The University of Tokyo
CREST, Japan Science and Technology Agency)
- Shigetoshi Sano
(Kochi Medical School, Kochi University, Kohasu)
- Akiko Sugahara-Tobinai
(Institute of Development, Aging and Cancer, Tohoku University)
- Toshiyuki Takai
(Institute of Development, Aging and Cancer, Tohoku University)
- Umeharu Ohto
(Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo)
- Toshiyuki Shimizu
(CREST, Japan Science and Technology Agency
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo)
- Shin-ichiroh Saitoh
(The Institute of Medical Science, The University of Tokyo)
- Kensuke Miyake
(The Institute of Medical Science, The University of Tokyo
Laboratory of Innate Immunity, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo)
Abstract
Toll-like receptor 7 (TLR7) senses microbial-derived RNA but can also potentially respond to self-derived RNA. To prevent autoimmune responses, TLR7 is thought to localize in endolysosomes. Contrary to this view, we show here that TLR7 is present on the cell surface of immune cells and that TLR7 responses can be inhibited by an anti-TLR7 antibody. The anti-TLR7 antibody is internalized with TLR7 and accumulates in endolysosomes as an immune complex. TLR7 responses in dendritic cells, macrophages and B cells are all inhibited by the anti-TLR7 antibody. Furthermore, the anti-TLR7 antibody inhibits in vivo cytokine production induced by a TLR7 ligand. Spontaneous TLR7 activation in Unc93b1D34A/D34A mice causes lethal inflammation. Progressive inflammation such as splenomegaly, thrombocytopenia and chronic active hepatitis are ameliorated by anti-TLR7 antibody treatment. These results demonstrate that cell surface TLR7 is a promising target for therapeutic intervention in autoimmune diseases.
Suggested Citation
Atsuo Kanno & Natsuko Tanimura & Masayuki Ishizaki & Kentaro Ohko & Yuji Motoi & Masahiro Onji & Ryutaro Fukui & Takaichi Shimozato & Kazuhide Yamamoto & Takuma Shibata & Shigetoshi Sano & Akiko Sugah, 2015.
"Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases,"
Nature Communications, Nature, vol. 6(1), pages 1-12, May.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7119
DOI: 10.1038/ncomms7119
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7119. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.